Antiferroptosis therapy alleviated the development of atherosclerosis

Abstract

Ferroptosis has been confirmed to be associated with various diseases, but the relationship between ferroptosis and atherosclerosis (AS) remains unclear. Our research detailly clarified the roles of ferroptosis in three continuous and main pathological stages of AS respectively (injury of endothelial cells [ECs], adhesion of monocytes, and formation of foam cells). We confirmed that oxidized low-density lipoprotein (ox-LDL), the key factor in the pathogenesis of AS, strongly induced ferroptosis in ECs. Inhibition of ferroptosis repressed the adhesion of monocytes to ECs by inhibiting inflammation of ECs. Ferroptosis also participated in the formation of foam cells and lipids by regulating the cholesterol efflux of macrophages. Further research confirmed that ox-LDL repressedthe activity of glutathione peroxidase 4 (GPX4), the classic lipid peroxide scavenger. Treatment of a high-fat diet significantly induced ferroptosis in murine aortas and aortic sinuses, which was accompanied by AS lesions and hyperlipidemia. Treatment with ferroptosis inhibitors significantly reduced ferroptosis, hyperlipidemia, and AS lesion development. In conclusion, our research determined that ox-LDL induced ferroptosis by repressing the activity of GPX4. Antiferroptosis treatment showed promising treatment effects in vivo. Ferroptosis-associated indexes also showed promising diagnostic potential in AS patients.

Keywords

atherosclerosis / endothelial cells / ferroptosis / glutathione peroxidase 4 / oxidized low-density lipoprotein

References

1	SS Virani, A Alonso, HJ Aparicio, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254-e743.
2	M Kowara, A Cudnoch-Jedrzejewska. Pathophysiology of atherosclerotic plaque development-contemporary experience and new directions in research. Int J Mol Sci. 2021;22(7):3513.
3	S Nan, Y Wang, C Xu, H Wang. Interfering microRNA-410 attenuates atherosclerosis via the HDAC1/KLF5/IKBα/NF-κB axis. Mol Ther Nucleic Acids. 2021;24:646-657.
4	D Wang, Y Yang, Y Lei, et al. Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacol Rev. 2019;71(4):596-670.
5	P Koppula, L Zhuang, B Gan. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2020.
6	Y Zhang, RV Swanda, L Nie, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021;12(1):1589.
7	T Bai, M Li, Y Liu, Z Qiao, Z Wang. Inhibition of ferroptosis alleviates atherosclerosis through attenuating lipid peroxidation and endothelial dysfunction in mouse aortic endothelial cell. Free Radic Biol Med. 2020;160:92-102.
8	S Ouyang, J You, C Zhi, et al. Ferroptosis: the potential value target in atherosclerosis. Cell Death Dis. 2021;12(8):782.
9	Y Lv, S Zhang, X Weng, et al. Estrogen deficiency accelerates postmenopausal atherosclerosis by inducing endothelial cell ferroptosis through inhibiting NRF2/GPX4 pathway. FASEB J. 2023;37(6):e22992.
10	XH Yu, YC Fu, DW Zhang, K Yin, CK Tang. Foam cells in atherosclerosis. Clin Chim Acta. 2013;424:245-252.
11	HJ Pownall, C Rosales, BK Gillard. High-density lipoproteins, reverse cholesterol transport and atherogenesis. Nat Rev Cardiol. 2021;18(10):712-723.
12	Y Yao, Z Chen, H Zhang, et al. Selenium-GPX4 axis protects follicular helper T cells from ferroptosis. Nat Immunol. 2021;22(9):1127-1139.
13	BR Stockwell, JP FriedmannAngeli, H Bayir, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273-285.
14	Z Wu, B Wu, X Lv, et al. Serumal lipidomics reveals the anti-inflammatory effect of flax lignans and sinapic acid in high-fat-diet-fed mice. J Agric Food Chem. 2021;69(32):9111-9123.
15	Y Zhou, H Zhou, L Hua, et al. Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis. Free Radic Biol Med. 2021;171:55-68.
16	X Jiang, Z Yang, AN Chandrakala, D Pressley, S Parthasarathy. Oxidized low density lipoproteins–do we know enough about them? Cardiovasc Drugs Ther. 2011;25(5):367-377.
17	A Stamenkovic, KA O'Hara, DC Nelson, et al. Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2021;320(3):H1170-h1184.
18	CJ Liang, SH Wang, YH Chen, et al. Viscolin reduces VCAM-1 expression in TNF-alpha-treated endothelial cells via the JNK/NF-kappaB and ROS pathway. Free Radic Biol Med. 2011;51(7):1337-1346.
19	AA Kapralov, Q Yang, HH Dar, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16(3):278-290.
20	Y Fan, J Wang, L Wei, B He, C Wang, B Wang. Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-κB pathway. Int J Cardiol. 2011;152(1):49-55.
21	A Sindrilaru, T Peters, S Wieschalka, et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 2011;121(3):985-997.
22	H Huang, P Koelle, M Fendler, et al. Induction of inducible nitric oxide synthase (iNOS) expression by oxLDL inhibits macrophage derived foam cell migration. Atherosclerosis. 2014;235(1):213-222.
23	K Bersuker, JM Hendricks, Z Li, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688-692.
24	Y Li, D Feng, Z Wang, et al. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Cell Death Differ. 2019;26(11):2284-2299.
25	Y Yang, M Luo, K Zhang, et al. Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma. Nat Commun. 2020;11(1):433.
26	I Ingold, C Berndt, S Schmitt, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172(3):409-422. e21.
27	G Lei, Y Zhang, P Koppula, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30(2):146-162.
28	WS Yang, R SriRamaratnam, ME Welsch, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1-2):317-331.
29	P Libby. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524-533.
30	YF Bai, SW Wang, XX Wang, et al. The flavonoid-rich Quzhou Fructus Aurantii extract modulates gut microbiota and prevents obesity in high-fat diet-fed mice. Nutr Diabetes. 2019;9(1):30.
31	W Wei, W Jiang, Z Tian, et al. Fecal g. Streptococcus and g. Eubacterium_coprostanoligenes_group combined with sphingosine to modulate the serum dyslipidemia in high-fat diet mice. Clin Nutr. 2021;40(6):4234-4245.
32	PV Chang, L Hao, S Offermanns, R Medzhitov. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA. 2014;111(6):2247-2252.
33	H Sang, Y Xie, X Su, et al. Mushroom Bulgaria inquinans modulates host immunological response and gut microbiota in mice. Front Nutr. 2020;7:144.
34	I Milosevic, A Vujovic, A Barac, et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. Int J Mol Sci. 2019;20(2):395.
35	SY Lee, IK Hong, BR Kim, et al. Activation of sphingosine kinase 2 by endoplasmic reticulum stress ameliorates hepatic steatosis and insulin resistance in mice. Hepatology (Baltimore, Md). 2015;62(1):135-146.
36	H Zhang, E Zhang, H Hu. Role of ferroptosis in non-alcoholic fatty liver disease and its implications for therapeutic strategies. Biomedicines. 2021;9(11):1660.
37	X Song, J Liu, F Kuang, et al. PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis. Cell Rep. 2021;34(8):108767.
38	SK Tan, I Mahmud, F Fontanesi, et al. Obesity-dependent adipokine chemerin suppresses fatty acid oxidation to confer ferroptosis resistance. Cancer Discov. 2021;11(8):2072-2093.
39	G Tarantino, C Porcu, M Arciello, P Andreozzi, C Balsano. Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability. J Gastroenterol Hepatol. 2018;33(8):1511-1517.
40	F Li, X Wu, H Liu, et al. Copper depletion strongly enhances ferroptosis via mitochondrial perturbation and reduction in antioxidative mechanisms. Antioxidants (Basel, Switzerland). 2022;11(11):2084.
41	M Asperti, S Bellini, E Grillo, et al. H-ferritin suppression and pronounced mitochondrial respiration make hepatocellular carcinoma cells sensitive to RSL3-induced ferroptosis. Free Radical Biol Med. 2021;169:294-303.
42	H Liu, F Forouhar, T Seibt, et al. Characterization of a patient-derived variant of GPX4 for precision therapy. Nat Chem Biol. 2022;18(1):91-100.
43	Z Yang, W Su, X Wei, et al. HIF-1α drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep. 2023;42(8):112945.
44	Z Yang, R Huang, X Wei, W Yu, Z Min, M Ye. The SIRT6-autophagy-Warburg effect axis in papillary thyroid cancer. Front Oncol. 2020;10:1265.
45	Y Huang, L Zhu, J Tan, et al. Correlation between SHP-1 and carotid plaque vulnerability in humans. Cardiovasc Pathol. 2020;49:107258.
46	S Nikeghbalian, R Rahimi, H Nikoupour, et al. Correlation between HDL2, HDL3 and serum ferritin levels with fatty liver and NAFLD activity score (NAS) in liver histology of organ donors. BMC Gastroenterol. 2021;21(1):405.